Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NEOGENOMICS INC Director's Dealing 2016

May 4, 2016

32227_dirs_2016-05-03_d1fde894-0e3b-4adf-8960-3ae894b84a35.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2016-04-20

Reporting Person: CARDOZA GEORGE (Chief Financial Officer)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2016-04-20 Stock Option (Right to Buy) $7.15 A 200000 Acquired 2021-04-20 Common Stock (200000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 189089 Direct
Common Stock 20000 Indirect

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option (Right to Buy) $3.45 2019-03-05 Common Stock (30000) 30000 Direct
Stock Option (Right to Buy) $4.78 2020-05-04 Common Stock (200000) 200000 Direct

Footnotes

F1: On March 5, 2014 Mr. Cardoza was granted an option to purchase 30,000 shares. These options vest ratably over the first three anniversary dates of the grant.

F2: On May 4, 2015 Mr. Cardoza was granted an option to purchase 200,000 shares. These options vest ratably over the first three anniversary dates of the grant.

F3: On April 20, 2016, Mr. Cardoza was granted 200,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.